EFFECT OF STILBAMIDINE THERAPY ON EXPERIMENTAL BLASTOMYCES - DERMATITIDIS INFECTIONS IN MICE

[摘要] Female albino mice were infected intraperitoneally with a yeast phase suspension of B. dermatitidis in mucin and treated intraperitoneally with stilbamidine daily for 11 days. The TD50 was 0.839 mg./dose and the PD50 was 0.06 mg./dose. Further study of stilbamidine as a possible agent for treatment of blasto-mycosis in humans appears to be justified.